Compare Ascendis Pharma A/S (ASND) vs Heron Therapeutics Inc (HRTX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ascendis Pharma A/S vs Heron Therapeutics Inc — how do they compare? Ascendis Pharma A/S trades at $253.76 (market cap $16.67B), while Heron Therapeutics Inc trades at $0.32 (market cap $61.47M). The key difference: Ascendis Pharma A/S is far larger — about 271.2× Heron Therapeutics Inc's market cap, and Ascendis Pharma A/S is trading nearer its 52-week high, Heron Therapeutics Inc nearer its low. Which is the better fit depends on your goals.
| ASND | HRTX | |
|---|---|---|
Market Cap | $16.67B | $61.47M |
Sector | Health | Health |
52-Week High | $277.18 | $1.49 |
52-Week Low | $189.74 | $0.32 |
Enterprise Value | $17.04B | $168.21M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ascendis Pharma A/S
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.
Read more on ASND →About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →
